Lucid Diagnostics (LUCD) Depreciation and Depletion (2021 - 2022)
Lucid Diagnostics (LUCD) reported Depreciation and Depletion of $24000.0 for Q1 2022, up 700.0% on a YoY basis from $3000.0 in Q1 2021, and up 4216.55% quarter-over-quarter from $556.0 in Q4 2021.
Lucid Diagnostics (LUCD) Depreciation and Depletion (2021 - 2022) Analysis & Trends
Lucid Diagnostics has reported Depreciation and Depletion for 2 years, with the latest figure at $24000.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 308.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 29.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Lucid Diagnostics | 149.20 Mn | 121.33 Mn | -325,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 24,000.00 |
| Mar 31, 2022 | 24,000.00 |
| Dec 31, 2021 | 556.00 |
| Dec 31, 2021 | 556.00 |
| Mar 31, 2021 | 3,000.00 |
| Mar 31, 2021 | 3,000.00 |